alzheon.comBioTechFounded: 2013Funding to Date: $89.27MM
Alzheon is a biotechnology company focusued on developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.
For more details on financing and valuation for Alzheon, register or login.
Already registered? Click here to log in
To read this article and more news on Alzheon, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.